Medical Devices

A new alliance aims to get an FDA-cleared device for a painful chemo side effect into patients' hands, tackling the hidden barriers of healthcare logistics.

Buffalo's Top Seedz is doubling production and shifting to sustainable packaging. A deep dive into the strategy fueling a rising healthy snack empire.

PGT's partnership with Habitat and HGTV stars is more than charity. It’s a strategic move to demonstrate product value and build unshakeable brand loyalty.

A flood of CPSC recalls, from choking-hazard toys to exploding vaporizers, reveals systemic failures in protecting consumers, especially on online marketplaces.

Courtney Adeleye, who built a $100M brand, returns to CURLFEST® as a leader. Her journey reveals a new blueprint for innovation and representation.

A deal between a Korean innovator and a Baxter subsidiary is set to replace the surgical microscope, promising better ergonomics and a future of AI-guided surgery.

Nuwellis bets on educating hundreds of physicians on its Aquadex system, a high-stakes strategy to combat fluid overload and secure its place in medicine.

Utah's Co-Diagnostics is transferring its AI-powered diagnostic platform to a Saudi JV. It's a bold move to crack a booming market and a critical test of its strategy.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

Two women-led Canadian brands are partnering, but the real story isn't the sale. It's a masterclass in resilient, values-driven business for a new era.

Nephros is moving from a product company to a service-based model. We unpack the strategy, financial risks, and why this pivot could redefine its market.

As OMS Energy prepares its FY2026 results, its performance offers a unique window into the future of oil & gas in the pivotal Asia-MENA corridor.

A 'dream team' of pharma veterans has raised $180M to advance a next-gen oral drug, promising to transform the multi-billion dollar IBD market.

At BIO 2026, Transpire Bio isn't just presenting; it's pitching a new paradigm for medicine, using inhalation to tackle everything from diabetes to cancer.

As regulators tighten their grip on PFAS, Claros Technologies adds a seasoned growth expert to its board, aiming to replicate AI-sector scaling success.

As EU F-gas rules tighten, Systemair's new 'plug-and-play' unit using natural refrigerant R290 signals a major shift in commercial building infrastructure.

An AMWC 2026 award for RRS® HA Long Lasting signals a market shift. How Skin Tech Pharma Group is creating a new category beyond fillers and boosters.

With a $110M boost, Nyxoah is bringing its innovative, battery-free sleep apnea device to the US. Is this the disruption patients have been waiting for?

Delisted and facing market headwinds, Allurion is executing a reverse stock split. Can this financial maneuver revive its stock and fund its U.S. expansion?

A strategic hire signals a new phase for Swisslog Healthcare, betting that expert storytelling is the key to unlocking the full potential of its robotic solutions.